Research and Development

Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …

UK marketing and communications agency Liberation Unlimited has promoted Danielle Guildford-Sharp to the role of account manager. Since joining Liberation …

British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …

Adding to its latest string of deals Pfizer has acquired vaccine developer Redvax – the pre-clinical arm of Swiss company …

Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …

A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced an appointment of a new director for The Clinical Practice …

Cempra Pharmaceuticals has become the first company to publish results from a Phase III study completed under FDA regulations governing …

Industry analysts predict 2015 will be another year of growth for the pharma, after approvals of new drugs soared to …

The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …

US medical device firm Echo Therapeutics has appointed Alan Schoenbart as its chief financial officer.Schoenbart who has more than 30 …

Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …

Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer.  Reporting …

Six medicines have been selected to move to the next stage of the EMA’s adaptive pathways pilot project, to explore …

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …